E-Articles - Health and Fitness

Studies have found that there is an estimated five-fold increase in psoriasis for those with Crohn’s disease. To put that into better perspective, approximately 2% of Americans

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

are affected by psoriasis, yet more than 11% of Crohn’s sufferers are affected by psoriasis. It seems more and more likely that a link between Crohn’s disease and psoriasis exi

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

ts.

What is psoriasis? Psoriasis is a chronic condition that affects the skin and joints. It typically causes red scaly patches on the skin that looks like a severe rash. The

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

scales on the red patch of skin have a silvery hue and are known as psoriatic plaques and are the result of inflammation and excessive skin production. The most common areas o

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

the skin that are affected by psoriasis include the knees and elbows. However, psoriasis can occur anywhere on the body, even on the genitals or the scalp. Like Crohn’s, psori

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

asis is not contagious.

What is the link? Researchers believe the crohns psoriasis link lies within a person’s genes. Just like Crohn’s, psoriasis is the result of a malfunctio

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

ing immune system and is considered an immune-mediated condition. If a person has a history of psoriasis within their family, and these genes have been passed on, this person ma

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

y not only be at risk for psoriasis, but also another immune-mediated condition such as type 1 diabetes, rheumatoid arthritis, or Crohn’s disease.

In fact, research suggests tha

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

the risk of developing psoriasis and/or another immune-mediated condition, especially diabetes or Crohn’s disease, significantly increases in those who have a close blood relati

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

ve with psoriasis.

If it is true that Crohn’s and psoriasis are caused by the same immune system malfunction, it would likely be best to treat crohns psoriasis as one condition

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

nstead of as two separate problems. Although those who have psoriasis and those who have Crohn’s will experience different symptoms, and each condition affects separate areas o

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

the body, they still maintain some similarities in regards to flare ups.

For instance, stress and alcohol consumption are both prime candidates for triggering a Crohn’s and pso

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

riasis flare up. In addition, some believe that a person’s diet can cause an active case of psoriasis, and diet also plays an important role in regulating Crohn’s.

How can croh

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

s psoriasis be treated together? Even though you may need to treat these problems separately, certain medications such as Remicade (Infliximab) may be able to treat them togethe

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

r. Separate studies have found Remicade to be effective at treating both Crohn’s Disease and psoriasis. The reason is because Remicade is an anti-TNF medication. Tumor necrosi

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

factor (TNF) is known to be the culprit behind the inflammation that occurs in Crohn’s and psoriasis.

Remicade sooths certain parts of the body’s immune system that are thought

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

to aggravate the condition and cause symptoms. Essentially, Remicade has been designed to improve the natural response the body has towards disease.

Remicade is a powerful cro

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

ns psoriasis treatment and is administered through intravenous injection over a defined treatment schedule. Many participants in both the Crohn’s and psoriasis studies successfu

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

lly achieved remission of their conditions with no or few adverse side effects.

Remicade is not for everyone, so be sure to talk to your doctor about possible medications if you

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

suffer from crohns psoriasis. You should also find out if there are any other treatments or alternative therapies that your doctor can recommend which may help you attain relief

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.e-article.org.ua/article/264310/e-article-Understanding-the-Crohns-Psoriasis-Connection.html">Understanding the Crohns Psoriasis Connection</a>

BB link (for phorums):
[url=http://www.e-article.org.ua/article/264310/e-article-Understanding-the-Crohns-Psoriasis-Connection.html]Understanding the Crohns Psoriasis Connection[/url]

Payday loans, most referred to as cash advance, is short-term type of loan in which most employees apply for in order to fulfill their other financial needs in the middle of paychecks. Usually those who lives from payday-to-payday basis often experience cash shortage.

Read reviews of the most popular Logitech computer speakers, including the X-230, X-530, X620, and Z-5300e.

Looking for a skin care product that reduces wrinkles, clears up acne, scars, and causes other imperfections to vanish without a trace? Read this in depth review on Revitol's skin care products and determine if this is exactly what you are looking for.

Tags

Links

E-Articles - Understanding the Crohns Psoriasis Connection

Related Articles: